Akèy › Atrit psoryatik › North Carolina
Etid klinik pou Atrit psoryatik nan North Carolina
11 etid pou Atrit psoryatik ap chèche patisipan nan sit nan North Carolina.
Vil nan North Carolina
Tèks ofisyèl etid la (Anglè)
A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Biologic-experienced and Biologic-naive Participants With Active Psoriatic Arthritis
- Joint and Muscle Research Institute, Charlotte
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT06807424A Study to Evaluate the Efficacy and Safety of JNJ-88545223 for the Treatment of Participants With Active Psoriatic Arthritis
- Joint and Muscle Research Institute, Charlotte
- Onsite Clinical Solutions, Salisbury
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT07321873A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)
- Up0122 106, Chapel Hill
- Up0122 102, Durham
Ap rekriteFaz 1
Laj 18 ak plis · Fanm · Mizajou Sep 18, 2026 · NCT06888193A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines
- Accellacare of Hickory, Hickory
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 17, 2026 · NCT06671483Study to Evaluate Tulisokibart in Adults With Psoriatic Arthritis (MK-7240-015)
- Joint and Muscle Research Institute ( Site 5108), Charlotte
Ap rekriteFaz 2
Laj 18 a 80 · Tout sèks · Mizajou Sep 14, 2026 · NCT07486960Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-TNFα Inadequate Response
- Clinical Site, Charlotte
- Clinical Site, Leland
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 11, 2026 · NCT06641089A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic Medicines
- DJL Clinical Research | Charlotte, NC, Charlotte
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT06671496A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab
- University of North Carolina - Children's Hospital /ID# 259286, Chapel Hill
Ap rekriteFaz 3
Laj 5 a 17 · Tout sèks · Mizajou Sep 1, 2026 · NCT06100744A Study to Assess Concentration of TREMFYA in Breast Milk of Lactating Women Who Are Receiving TREMFYA Therapeutically
- University of North Carolina at Chapel Hill, Chapel Hill
Ap rekriteFaz 4
Laj 18 ak plis · Fanm · Mizajou Aug 28, 2026 · NCT07654751Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry
- University of North Carolina at Chapel Hill, Chapel Hill
- Levine Children's Hospital / Carolinas Medical Center, Charlotte
- Duke Children's Hospital & Health Center, Durham
- ak 1 plis
Ap rekriteEtid obsèvasyon
Jiska laj 21 · Tout sèks · Mizajou Aug 27, 2026 · NCT02418442Study to Evaluate Pregnancy Outcomes in Risankizumab Exposed Pregnancies Relative to Those Non-risankizumab Exposed Pregnancies in Women With FDA Approved Indications
- Evidera, a PPD Business Unit /ID# 238688, Morrisville
Ap rekriteEtid obsèvasyon
Tout laj · Fanm · Mizajou Jul 17, 2025 · NCT04846959Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.